Illumina (ILMN) Stock Forecast & Price Target

Compare

4,607 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ILMN Analyst Ratings

Hold

4 Buy

5 Hold

3 Sell

Based on 12 analysts giving stock ratings to

Illumina

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ILMN Stock 12 Month Forecast

Average Price Target

$117.25

▼(-13.06% Downside)

Based on 12 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $117.25 with a high forecast of $195.00 and a low forecast of $80.00. The average price target represents a -13.06% change from the last price of $134.87.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"75":"$75","196":"$196","105.25":"$105.3","135.5":"$135.5","165.75":"$165.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":195,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$195.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":117.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$117.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$80.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[75,105.25,135.5,165.75,196],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,128.72,133.81846153846155,138.91692307692307,144.01538461538462,149.11384615384617,154.2123076923077,159.31076923076924,164.40923076923076,169.5076923076923,174.60615384615386,179.70461538461538,184.80307692307693,189.90153846153845,{"y":195,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,128.72,127.83769230769231,126.95538461538462,126.07307692307693,125.19076923076923,124.30846153846154,123.42615384615385,122.54384615384615,121.66153846153846,120.77923076923076,119.89692307692307,119.01461538461538,118.13230769230769,{"y":117.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,128.72,124.9723076923077,121.22461538461539,117.47692307692307,113.72923076923077,109.98153846153846,106.23384615384616,102.48615384615385,98.73846153846154,94.99076923076923,91.24307692307693,87.49538461538461,83.74769230769232,{"y":80,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":145.15,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.63,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.74,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.74,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.51,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.09,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.15,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.66,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.82,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.26,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.54,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":128.72,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$195.00

Average Price Target$117.25

Lowest Price Target$80.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Westenberg

Piper Sandler

$185→$195

Buy

44.58%

Upside

Reiterated

11/10/25

Illumina price target raised to $195 from $185 at Piper SandlerIllumina price target raised to $195 from $185 at Piper Sandler

Michael Ryskin

Bank of America Securities

$80

Sell

-40.68%

Downside

Reiterated

11/06/25

Bank of America Securities Keeps Their Sell Rating on Illumina (ILMN)

Kyle Mikson CFA

Canaccord Genuity

$112

Hold

-16.96%

Downside

Reiterated

11/06/25

Illumina (ILMN) Gets a Hold from Canaccord Genuity

Daniel Arias

Stifel Nicolaus

$135

Buy

0.10%

Upside

Reiterated

11/06/25

Illumina (ILMN) Receives a Buy from Stifel Nicolaus

Daniel Brennan

TD Cowen

$110→$115

Hold

-14.73%

Downside

Reiterated

10/31/25

Illumina's Hold Rating: Balancing Growth Potential with Competitive and Financial Challenges

Dan Leonard

UBS

$110→$120

Hold

-11.03%

Downside

Reiterated

10/31/25

Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), Baxter International (NYSE: BAX) and Illumina (NASDAQ: ILMN)

Catherine Ramsey Schulte

Robert W. Baird

$105→$109

Hold

-19.18%

Downside

Reiterated

10/31/25

Illumina price target raised to $109 from $105 at BairdIllumina price target raised to $109 from $105 at Baird

Vijay Kumar

Evercore ISI

$132→$142

Buy

5.29%

Upside

Reiterated

10/31/25

Illumina price target raised to $142 from $132 at Evercore ISIIllumina price target raised to $142 from $132 at Evercore ISI

Casey Woodring

J.P. Morgan

$100→$105

Hold

-22.15%

Downside

Reiterated

10/31/25

Illumina price target raised to $105 from $100 at JPMorganIllumina price target raised to $105 from $100 at JPMorgan

Luke Sergott

Barclays

$95→$100

Sell

-25.85%

Downside

Reiterated

10/31/25

Barclays Sticks to Their Sell Rating for Illumina (ILMN)

Patrick B Donnelly

Citi

$80

Sell

-40.68%

Downside

Reiterated

10/15/25

We assign ILMN a Sell rating. Our $80 target price applies a 50/50 split between a 12.5x EV/EBITDA multiple on our Q5-Q8 EBITDA estimate and a 14.5x P/E multiple on our Q5-Q8 EPS estimate.

Subbu Nambi

Guggenheim

$114

Buy

-15.47%

Downside

Reiterated

09/26/25

Illumina (ILMN) Gets a Buy from GuggenheimWe reiterate our Buy rating.

Conor McNamara

RBC Capital

$126→$124

Buy

-8.06%

Downside

Reiterated

09/02/25

Illumina (ILMN) Receives a Buy from RBC Capital

Narumi Nakagiri

Daiwa

$94

Hold

-30.30%

Downside

Downgraded

08/12/25

Illumina downgraded to Neutral from Outperform at DaiwaIllumina downgraded to Neutral from Outperform at Daiwa

Sung Ji Nam

Scotiabank

$125

Hold

-7.32%

Downside

Reiterated

08/05/25

Illumina (ILMN) Gets a Hold from Scotiabank

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Westenberg

Piper Sandler

$185→$195

Buy

44.58%

Upside

Reiterated

11/10/25

Illumina price target raised to $195 from $185 at Piper SandlerIllumina price target raised to $195 from $185 at Piper Sandler

Michael Ryskin

Bank of America Securities

$80

Sell

-40.68%

Downside

Reiterated

11/06/25

Bank of America Securities Keeps Their Sell Rating on Illumina (ILMN)

Kyle Mikson CFA

Canaccord Genuity

$112

Hold

-16.96%

Downside

Reiterated

11/06/25

Illumina (ILMN) Gets a Hold from Canaccord Genuity

Daniel Arias

Stifel Nicolaus

$135

Buy

0.10%

Upside

Reiterated

11/06/25

Illumina (ILMN) Receives a Buy from Stifel Nicolaus

Daniel Brennan

TD Cowen

$110→$115

Hold

-14.73%

Downside

Reiterated

10/31/25

Illumina's Hold Rating: Balancing Growth Potential with Competitive and Financial Challenges

Dan Leonard

UBS

$110→$120

Hold

-11.03%

Downside

Reiterated

10/31/25

Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), Baxter International (NYSE: BAX) and Illumina (NASDAQ: ILMN)

Catherine Ramsey Schulte

Robert W. Baird

$105→$109

Hold

-19.18%

Downside

Reiterated

10/31/25

Illumina price target raised to $109 from $105 at BairdIllumina price target raised to $109 from $105 at Baird

Vijay Kumar

Evercore ISI

$132→$142

Buy

5.29%

Upside

Reiterated

10/31/25

Illumina price target raised to $142 from $132 at Evercore ISIIllumina price target raised to $142 from $132 at Evercore ISI

Casey Woodring

J.P. Morgan

$100→$105

Hold

-22.15%

Downside

Reiterated

10/31/25

Illumina price target raised to $105 from $100 at JPMorganIllumina price target raised to $105 from $100 at JPMorgan

Luke Sergott

Barclays

$95→$100

Sell

-25.85%

Downside

Reiterated

10/31/25

Barclays Sticks to Their Sell Rating for Illumina (ILMN)

Patrick B Donnelly

Citi

$80

Sell

-40.68%

Downside

Reiterated

10/15/25

We assign ILMN a Sell rating. Our $80 target price applies a 50/50 split between a 12.5x EV/EBITDA multiple on our Q5-Q8 EBITDA estimate and a 14.5x P/E multiple on our Q5-Q8 EPS estimate.

Subbu Nambi

Guggenheim

$114

Buy

-15.47%

Downside

Reiterated

09/26/25

Illumina (ILMN) Gets a Buy from GuggenheimWe reiterate our Buy rating.

Conor McNamara

RBC Capital

$126→$124

Buy

-8.06%

Downside

Reiterated

09/02/25

Illumina (ILMN) Receives a Buy from RBC Capital

Narumi Nakagiri

Daiwa

$94

Hold

-30.30%

Downside

Downgraded

08/12/25

Illumina downgraded to Neutral from Outperform at DaiwaIllumina downgraded to Neutral from Outperform at Daiwa

Sung Ji Nam

Scotiabank

$125

Hold

-7.32%

Downside

Reiterated

08/05/25

Illumina (ILMN) Gets a Hold from Scotiabank

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

1 Month

xxx

Success Rate

21/37 ratings generated profit

Average Return

+1.78%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 56.76% of your transactions generating a profit, with an average return of +1.78% per trade.

3 Months

xxx

Success Rate

20/37 ratings generated profit

Average Return

+2.88%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 54.05% of your transactions generating a profit, with an average return of +2.88% per trade.

1 Year

Doug SchenkelWolfe Research

Success Rate

25/32 ratings generated profit

Average Return

+19.01%

reiterated a buy rating 10 months ago

Copying Doug Schenkel's trades and holding each position for 1 Year would result in 78.13% of your transactions generating a profit, with an average return of +19.01% per trade.

2 Years

xxx

Success Rate

23/32 ratings generated profit

Average Return

+40.56%

reiterated a xxx

rating 10 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 71.88% of your transactions generating a profit, with an average return of +40.56% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILMN Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ILMN has received 7 Buy Ratings, 14 Hold Ratings, and 7 Sell Ratings. ILMN average Analyst price target in the past 3 months is 117.25.

Each month's total comprises the sum of three months' worth of ratings.

ILMN Financial Forecast

ILMN Earnings Forecast

Next quarter’s earnings estimate for ILMN is $1.22 with a range of $1.18 to $1.30. The previous quarter’s EPS was $1.34. ILMN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.

ILMN Sales Forecast

Next quarter’s sales forecast for ILMN is $1.10B with a range of $1.09B to $1.12B. The previous quarter’s sales results were $1.08B. ILMN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.

ILMN Stock Forecast FAQ

What is ILMN’s average 12-month price target, according to analysts?

Based on analyst ratings, Illumina’s 12-month average price target is 117.25.

What is ILMN’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for ILMN, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ILMN a Buy, Sell or Hold?

Illumina has a consensus rating of Hold which is based on 4 buy ratings, 5 hold ratings and 3 sell ratings.

What is Illumina’s price target?

The average price target for Illumina is 117.25. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $195.00 ,the lowest forecast is $80.00. The average price target represents -13.06% Decrease from the current price of $134.87.

What do analysts say about Illumina?

Illumina’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of ILMN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Illumina (ILMN) Stock Forecast & Price Target

ILMN Analyst Ratings

ILMN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Illumina

ILMN Analyst Recommendation Trends

ILMN Financial Forecast

ILMN Earnings Forecast

ILMN Sales Forecast

ILMN Stock Forecast FAQ

Detailed List of Analyst Forecasts